Rein Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Rein Therapeutics, Inc. (RNTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $18.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-14
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $0.00.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-06-30 was $0.00.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-03-31 was $18.00K.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $18.00K, a 94.92% decline from fiscal 2024.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $354.00K.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2021 was $68.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $18.00K 10-K · filed 2026-03-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $18.00K 10-Q · filed 2025-11-14 | $18.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $18.00K 10-Q · filed 2026-08-14 | $18.00K derived: sum of 3 quarters · filed 2026-08-14 | $228.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $18.00K 10-Q · filed 2026-05-15 | $18.00K derived: sum of 2 quarters · filed 2026-05-15 | $228.00K derived: sum of 3 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $210.00K derived: sum of 2 quarters · filed 2026-03-26 | $354.00K 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $354.00K 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $144.00K 10-Q · filed 2025-08-14 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | $0.00 derived: sum of 2 quarters · filed 2024-04-15 | $0.00 derived: sum of 3 quarters · filed 2024-04-15 | $0.00 10-K · filed 2024-04-15 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $0.00 derived: sum of 2 quarters · filed 2022-11-01 | $0.00 10-Q · filed 2022-11-01 | $2.00K derived: sum of 4 quarters · filed 2023-03-20 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $2.00K derived: sum of 3 quarters · filed 2023-03-20 | $68.00K derived: sum of 4 quarters · filed 2023-03-20 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $2.00K derived: sum of 2 quarters · filed 2023-03-20 | $68.00K derived: sum of 3 quarters · filed 2023-03-20 | $68.00K derived: sum of 4 quarters · filed 2023-03-20 | |
| 2021-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $68.00K derived: sum of 2 quarters · filed 2023-03-20 | $68.00K derived: sum of 3 quarters · filed 2023-03-20 | $68.00K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $66.00K derived: sum of 2 quarters · filed 2022-11-01 | $66.00K 10-Q · filed 2022-11-01 | $66.00K derived: sum of 4 quarters · filed 2022-11-01 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $48.00K 10-Q · filed 2021-08-11 | $0.00 derived: sum of 3 quarters · filed 2022-08-15 | $0.00 derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2022-05-05 | $0.00 derived: sum of 3 quarters · filed 2022-05-05 | $0.00 derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $0.00 derived: sum of 3 quarters · filed 2022-03-28 | $0.00 10-K · filed 2022-03-28 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | $0.00 derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $0.00 10-Q · filed 2021-08-11 | $0.00 derived: sum of 3 quarters · filed 2021-08-11 | $0.00 derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-05-11 | $0.00 derived: sum of 3 quarters · filed 2021-05-11 | $0.00 derived: sum of 4 quarters · filed 2021-05-11 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $0.00 derived: sum of 2 quarters · filed 2021-03-24 | $0.00 derived: sum of 3 quarters · filed 2021-03-24 | $109.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $109.00K 10-Q · filed 2020-11-12 | $121.00K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $109.00K 10-Q · filed 2020-08-05 | $121.00K derived: sum of 3 quarters · filed 2020-08-05 | $121.00K derived: sum of 4 quarters · filed 2020-08-05 | |
| 2019-03-31 | $109.00K 10-Q · filed 2020-05-11 | $121.00K derived: sum of 2 quarters · filed 2020-05-11 | $121.00K derived: sum of 3 quarters · filed 2020-05-11 | $131.00K derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $12.00K derived: sum of 2 quarters · filed 2020-03-30 | $22.00K derived: sum of 3 quarters · filed 2020-03-30 | $105.00K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $10.00K derived: sum of 2 quarters · filed 2019-11-07 | $93.00K 10-Q · filed 2019-11-07 | $2.00K derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $93.00K 10-Q · filed 2019-08-06 | $2.00K derived: sum of 3 quarters · filed 2019-08-06 | $132.00K derived: sum of 4 quarters · filed 2019-08-06 | |
| 2018-03-31 | $83.00K 10-Q · filed 2019-05-08 | -$8.00K derived: sum of 2 quarters · filed 2019-05-08 | $122.00K derived: sum of 3 quarters · filed 2019-05-08 | $226.00K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | -$91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $39.00K derived: sum of 2 quarters · filed 2019-03-29 | $143.00K derived: sum of 3 quarters · filed 2019-03-29 | $165.00K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $234.00K derived: sum of 2 quarters · filed 2018-11-07 | $256.00K 10-Q · filed 2018-11-07 | $262.00K derived: sum of 4 quarters · filed 2018-11-07 | |
| 2017-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $126.00K 10-Q · filed 2018-08-07 | $132.00K derived: sum of 3 quarters · filed 2018-08-07 | $132.00K derived: sum of 4 quarters · filed 2018-08-07 | |
| 2017-03-31 | $22.00K 10-Q · filed 2018-05-09 | $28.00K derived: sum of 2 quarters · filed 2018-05-09 | $28.00K derived: sum of 3 quarters · filed 2018-05-09 | ||
| 2016-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $6.00K derived: sum of 2 quarters · filed 2018-04-02 | $12.00K 10-K · filed 2018-04-02 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $6.00K 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | $6.00K 10-Q · filed 2017-08-10 | ||||
| 2015-12-31 | $300.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |